Edgewise Therapeutics, Inc.
EWTX • NASDAQ • Stock Fundamentals
Edgewise Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kevin Koch, with a market cap of $3.7B.
Market Cap$3.7B
Employees92.0
CEOKevin Koch
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Edgewise Therapeutics, Inc. FAQ
Common questions about Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. (EWTX) has a market capitalization of $3.7B and trades on NASDAQ.
Edgewise Therapeutics, Inc. has approximately 92 employees.